SEC Info - Nano Mobile Healthcare, Inc.

SEC Info℠

Home

Help

Please Sign In

Nano Mobile Healthcare, Inc. – ‘8-K’ for 1/14/21

On: Friday, 1/14/22, at 7:44pm ET · As of: 1/18/22 · For: 1/14/21 · Accession #: 1721868-22-53 · File #: 0-55155

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/18/22  Nano Mobile Healthcare, Inc.      8-K:5       1/14/21   10:185K                                   FILING2SEC/FA

Current Report — Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     28K 
 5: R1          Cover                                               HTML     45K 
 8: XML         IDEA XML File -- Filing Summary                      XML     11K 
 6: XML         XBRL Instance -- f2svnth8k101521_htm                 XML     14K 
 7: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 3: EX-101.LAB  XBRL Labels -- vnth-20220114_lab                     XML     96K 
 4: EX-101.PRE  XBRL Presentations -- vnth-20220114_pre              XML     64K 
 2: EX-101.SCH  XBRL Schema -- vnth-20220114                         XSD     12K 
 9: JSON        XBRL Instance as JSON Data -- MetaLinks               25±    33K 
10: ZIP         XBRL Zipped Folder -- 0001721868-22-000053-xbrl      Zip     11K

‘8-K’ — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

iX: C: C: C: C: C: C: C: C:

i 0001497130 i false 0001497130 2021-01-14 2021-01-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM i 8-K

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): i January 14, 2021

i NANO MOBILE HEALTHCARE, INC.

(Exact Name of Registrant as Specified in its Charter)

i Nevada
(State or other jurisdiction
of incorporation)

i 000-55155
(Commission
File Number)

i 98-0659770
(I.R.S. Employer
Identification No.)

i 370 Amapola Avenue i Suite 200-A
i Torrance, i CA i 90501
(Address of Principal Executive Offices and Zip Code)

Registrant’s telephone number, including area code: i (424) i 358-1046

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

i ☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

i ☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

i ☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

i ☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol(s)

Name of each exchange on which registered

i Common Stock, par value of $0.00001

i VNTH

OTCMKTS

SECTION 5 – CORPORATE GOVERNANCE AND MANAGEMENT

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.

On January 14, the Company parted ways with Mr. David Noah Kittle, who was previously appointed President and CEO of the Company on October 14, 2021. Mr. Kittle's departure was not the result of any dispute or disagreement with the Company or the Company's Board of Directors on any matter relating to the operations, policies or practices of the Company. The Company needed a jolt and change of leadership to help it capitalize on emerging opportunities in the Web3, Gaming, Crypto and Metaverse industries. The Company has begun a search for a new President and CEO.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

NANO MOBILE HEALTHCARE, INC.

Date: January 14, 2022	By: /s/ *Frank I Igwealor*
	Name:	Frank I Igwealor, JD, MBA, CPA, CMA, CFM, MSRM, ESQ.
	Title:	Interim Chairman

Dates Referenced Herein and Documents Incorporated by Reference

This ‘8-K’ Filing	Date	Other Filings

Filed as of:	1/18/22	8-K
Filed on:	1/14/22
	10/14/21	8-K
For Period end:	1/14/21
		List all Filings

↑Top

Filing Submission 0001721868-22-000053 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)